Premium
Marathon with cystic fibrosis and bilateral lung transplant
Author(s) -
Stanghelle J. K.,
Koss J. O.,
Bjørtuft Ø.,
Geiran O.
Publication year - 2000
Publication title -
scandinavian journal of medicine and science in sports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.575
H-Index - 115
eISSN - 1600-0838
pISSN - 0905-7188
DOI - 10.1034/j.1600-0838.2000.010001042.x
Subject(s) - cystic fibrosis , medicine , lung , lung transplantation , fibrosis , pathology
The article presents studies performed before, during and after a marathon run (42 195 m) in a 32‐year‐old man who underwent a bilateral lung transplantation because of end‐stage cystic fibrosis (CF) 15 months prior to the race. Before the run his FEV 1 was 81% predicted, compared with 19% predicted before the operation, and his maximal oxygen uptake was 31.9 ml/kg −1 /min −1 . He completed the New York City Marathon 1998 without major problems in 7 h 8 min 50s. Pulmonary tests, biochemical changes and endocrine responses indicated transient changes, mostly as expected in healthy marathon runners. The case demonstrates that physiological trainability and psychological will power following a successful bilateral lung transplantation can transform a chronically ill CF patient into a robust marathon runner.